semaglutide 15mg
| Product Overview | |
| Generic Name | semaglutide 15mg |
| Brand Name(s) | MASHEMA |
| Form | Inject Pen |
| Strength | 15mg |
| Therapeutic Class | Glucagon-like peptide-1 (GLP-1) receptor agonist / analogue. |
| ATC Code | A10BJ06 |
| Manufacturing & Regulatory | |
| Manufacturer | Zydus Biosciences |
| Country | India |
| GMP Compliance | WHO/cGMP-compliant |
| COFEPRIS | Pending |
| Logistics & Export | |
| MOQ | 5 units |
| Shelf Life | 24 Months |
| Storage | Refrigerated (2–8 °C) |
| Incoterms | EXW/FOB/CIF negotiable |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
| Certificate of Analysis (COA) | Supplied per batch upon request |
Description
(semaglutide) is a once-weekly GLP-1 receptor agonist injectable indicated in the Indian launch/regulatory context for type 2 diabetes mellitus and obesity/weight management. It is intended to improve glycaemic control and support weight reduction under physician supervision, using a 15 mg / 3 mL cartridge platform administered through a reusable multi-dose pen
